Incannex Healthcare (IXHL) EBIT (2022 - 2026)

Incannex Healthcare has disclosed EBIT across 5 years of filings, most recently posting -$4.0 million for Q1 2026.

• EBIT for Q1 2026 came in at -$4.0 million, up 19.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.4 million (up 2.46% YoY), and the FY2025 annual result was -$23.8 million, up 20.81% from the prior year.
• EBIT came in at -$4.0 million for Q1 2026 at Incannex Healthcare, up from -$7.0 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$3.6 million in Q4 2022 to a low of -$9.7 million in Q2 2024.
• The 5-year median for EBIT is -$5.6 million (2024), against an average of -$5.9 million.
• Peak annual rise in EBIT reached 37.32% in 2024, while the deepest fall reached 132.33% in 2024.
• Incannex Healthcare's EBIT stood at -$3.6 million in 2022, then tumbled by 119.37% to -$8.0 million in 2023, then surged by 37.32% to -$5.0 million in 2024, then sank by 39.79% to -$7.0 million in 2025, then surged by 42.13% to -$4.0 million in 2026.
• The last three EBIT figures came in at -$4.0 million (Q1 2026), -$7.0 million (Q4 2025), and -$6.8 million (Q3 2025), per Business Quant data.